Shonali Midha, MD, and Amar Kelkar, MD, both of the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the real-life decision-making process that goes into evaluating patients with multiple myeloma for transplantation. They discuss determining patient eligibility and counseling patients as well as stem cell mobilization and the role of transplantation in light of treatment advances.